 | • レポートコード：MRC2-11QY11628 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病治療・ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓）市場規模、用途別（診断/クリニック、ICU、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病治療・ドラッグデリバリーの競争状況、市場シェア ・世界の糖尿病治療・ドラッグデリバリー市場：種類別市場規模 2015年-2020年（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・世界の糖尿病治療・ドラッグデリバリー市場：種類別市場規模予測 2021年-2026年（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・世界の糖尿病治療・ドラッグデリバリー市場：用途別市場規模 2015年-2020年（診断/クリニック、ICU、在宅医療） ・世界の糖尿病治療・ドラッグデリバリー市場：用途別市場規模予測 2021年-2026年（診断/クリニック、ICU、在宅医療） ・北米の糖尿病治療・ドラッグデリバリー市場分析：米国、カナダ ・ヨーロッパの糖尿病治療・ドラッグデリバリー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病治療・ドラッグデリバリー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病治療・ドラッグデリバリー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病治療・ドラッグデリバリー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market
The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diabetes Therapy and Drug Delivery Scope and Market Size
Diabetes Therapy and Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapy and Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties
Market segment by Type, the product can be split into
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market segment by Application, split into
Diagnostic/Clinics
ICUs
Home Healthcare
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Therapy and Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalable Insulin
1.4.3 Oral Insulin
1.4.4 Insulin Patches
1.4.5 CGM Systems
1.4.6 Artificial Pancreas
1.5 Market by Application
1.5.1 Global Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Therapy and Drug Delivery Market Perspective (2015-2026)
2.2 Global Diabetes Therapy and Drug Delivery Growth Trends by Regions
2.2.1 Diabetes Therapy and Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Therapy and Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Therapy and Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Therapy and Drug Delivery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapy and Drug Delivery Players by Market Size
3.1.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.2.1 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Therapy and Drug Delivery Revenue in 2019
3.3 Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.4 Key Players Diabetes Therapy and Drug Delivery Product Solution and Service
3.5 Date of Enter into Diabetes Therapy and Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
5.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetes Therapy and Drug Delivery Market Size (2015-2020)
6.2 Diabetes Therapy and Drug Delivery Key Players in North America (2019-2020)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
6.4 North America Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetes Therapy and Drug Delivery Market Size (2015-2020)
7.2 Diabetes Therapy and Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
8 China
8.1 China Diabetes Therapy and Drug Delivery Market Size (2015-2020)
8.2 Diabetes Therapy and Drug Delivery Key Players in China (2019-2020)
8.3 China Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
8.4 China Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetes Therapy and Drug Delivery Market Size (2015-2020)
9.2 Diabetes Therapy and Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetes Therapy and Drug Delivery Market Size (2015-2020)
10.2 Diabetes Therapy and Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
11 India
11.1 India Diabetes Therapy and Drug Delivery Market Size (2015-2020)
11.2 Diabetes Therapy and Drug Delivery Key Players in India (2019-2020)
11.3 India Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
11.4 India Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetes Therapy and Drug Delivery Market Size (2015-2020)
12.2 Diabetes Therapy and Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Introduction
13.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview
13.2.3 Medtronic Diabetes Therapy and Drug Delivery Introduction
13.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Diabetes Therapy and Drug Delivery Introduction
13.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Details
13.4.2 Novo Nordisk Business Overview
13.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Introduction
13.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.4.5 Novo Nordisk Recent Development
13.5 MannKind
13.5.1 MannKind Company Details
13.5.2 MannKind Business Overview
13.5.3 MannKind Diabetes Therapy and Drug Delivery Introduction
13.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.5.5 MannKind Recent Development
13.6 Enteris BioPharma
13.6.1 Enteris BioPharma Company Details
13.6.2 Enteris BioPharma Business Overview
13.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Introduction
13.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.6.5 Enteris BioPharma Recent Development
13.7 Dexcom
13.7.1 Dexcom Company Details
13.7.2 Dexcom Business Overview
13.7.3 Dexcom Diabetes Therapy and Drug Delivery Introduction
13.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.7.5 Dexcom Recent Development
13.8 Senseonics Holding
13.8.1 Senseonics Holding Company Details
13.8.2 Senseonics Holding Business Overview
13.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Introduction
13.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.8.5 Senseonics Holding Recent Development
13.9 Medtech
13.9.1 Medtech Company Details
13.9.2 Medtech Business Overview
13.9.3 Medtech Diabetes Therapy and Drug Delivery Introduction
13.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.9.5 Medtech Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Introduction
13.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Synertech
10.11.1 Synertech Company Details
10.11.2 Synertech Business Overview
10.11.3 Synertech Diabetes Therapy and Drug Delivery Introduction
10.11.4 Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
10.11.5 Synertech Recent Development
13.12 Zosano Pharma
10.12.1 Zosano Pharma Company Details
10.12.2 Zosano Pharma Business Overview
10.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Introduction
10.12.4 Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
10.12.5 Zosano Pharma Recent Development
13.13 Relmada Therapeutics
10.13.1 Relmada Therapeutics Company Details
10.13.2 Relmada Therapeutics Business Overview
10.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Introduction
10.13.4 Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
10.13.5 Relmada Therapeutics Recent Development
13.14 Eli Lilly
10.14.1 Eli Lilly Company Details
10.14.2 Eli Lilly Business Overview
10.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Introduction
10.14.4 Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
10.14.5 Eli Lilly Recent Development
13.15 Transdermal Specialties
10.15.1 Transdermal Specialties Company Details
10.15.2 Transdermal Specialties Business Overview
10.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Introduction
10.15.4 Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020)
10.15.5 Transdermal Specialties Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetes Therapy and Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Therapy and Drug Delivery Revenue
Table 3. Ranking of Global Top Diabetes Therapy and Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inhalable Insulin
Table 6. Key Players of Oral Insulin
Table 7. Key Players of Insulin Patches
Table 8. Key Players of CGM Systems
Table 9. Key Players of Artificial Pancreas
Table 10. Global Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Diabetes Therapy and Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Diabetes Therapy and Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2015-2020)
Table 14. Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Diabetes Therapy and Drug Delivery Market Growth Strategy
Table 20. Main Points Interviewed from Key Diabetes Therapy and Drug Delivery Players
Table 21. Global Diabetes Therapy and Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 22. Global Diabetes Therapy and Drug Delivery Market Share by Players (2015-2020)
Table 23. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2019)
Table 24. Global Diabetes Therapy and Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Diabetes Therapy and Drug Delivery Product Solution and Service
Table 27. Date of Enter into Diabetes Therapy and Drug Delivery Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 30. Global Diabetes Therapy and Drug Delivery Market Size Share by Type (2015-2020)
Table 31. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2021-2026)
Table 32. Global Diabetes Therapy and Drug Delivery Market Size Share by Application (2015-2020)
Table 33. Global Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 34. Global Diabetes Therapy and Drug Delivery Market Size Share by Application (2021-2026)
Table 35. North America Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 37. North America Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 38. North America Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 39. North America Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 40. North America Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 41. Europe Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 43. Europe Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 45. Europe Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 47. China Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 48. China Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 49. China Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 50. China Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 51. China Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 52. China Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 53. Japan Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 55. Japan Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 57. Japan Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 61. Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 63. Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 65. India Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 66. India Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 67. India Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 68. India Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 69. India Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 70. India Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 73. Central & South America Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 75. Central & South America Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Medtronic Company Details
Table 83. Medtronic Business Overview
Table 84. Medtronic Product
Table 85. Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 86. Medtronic Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Product
Table 90. Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 91. Sanofi Recent Development
Table 92. Novo Nordisk Company Details
Table 93. Novo Nordisk Business Overview
Table 94. Novo Nordisk Product
Table 95. Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 96. Novo Nordisk Recent Development
Table 97. MannKind Company Details
Table 98. MannKind Business Overview
Table 99. MannKind Product
Table 100. MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 101. MannKind Recent Development
Table 102. Enteris BioPharma Company Details
Table 103. Enteris BioPharma Business Overview
Table 104. Enteris BioPharma Product
Table 105. Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 106. Enteris BioPharma Recent Development
Table 107. Dexcom Company Details
Table 108. Dexcom Business Overview
Table 109. Dexcom Product
Table 110. Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 111. Dexcom Recent Development
Table 112. Senseonics Holding Business Overview
Table 113. Senseonics Holding Product
Table 114. Senseonics Holding Company Details
Table 115. Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 116. Senseonics Holding Recent Development
Table 117. Medtech Company Details
Table 118. Medtech Business Overview
Table 119. Medtech Product
Table 120. Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 121. Medtech Recent Development
Table 122. Johnson & Johnson Company Details
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Product
Table 125. Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 126. Johnson & Johnson Recent Development
Table 127. Synertech Company Details
Table 128. Synertech Business Overview
Table 129. Synertech Product
Table 130. Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 131. Synertech Recent Development
Table 132. Zosano Pharma Company Details
Table 133. Zosano Pharma Business Overview
Table 134. Zosano Pharma Product
Table 135. Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 136. Zosano Pharma Recent Development
Table 137. Relmada Therapeutics Company Details
Table 138. Relmada Therapeutics Business Overview
Table 139. Relmada Therapeutics Product
Table 140. Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 141. Relmada Therapeutics Recent Development
Table 142. Eli Lilly Company Details
Table 143. Eli Lilly Business Overview
Table 144. Eli Lilly Product
Table 145. Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 146. Eli Lilly Recent Development
Table 147. Transdermal Specialties Company Details
Table 148. Transdermal Specialties Business Overview
Table 149. Transdermal Specialties Product
Table 150. Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 151. Transdermal Specialties Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Therapy and Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Inhalable Insulin Features
Figure 3. Oral Insulin Features
Figure 4. Insulin Patches Features
Figure 5. CGM Systems Features
Figure 6. Artificial Pancreas Features
Figure 7. Global Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
Figure 8. Diagnostic/Clinics Case Studies
Figure 9. ICUs Case Studies
Figure 10. Home Healthcare Case Studies
Figure 11. Diabetes Therapy and Drug Delivery Report Years Considered
Figure 12. Global Diabetes Therapy and Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Diabetes Therapy and Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 14. Global Diabetes Therapy and Drug Delivery Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Diabetes Therapy and Drug Delivery Market Share by Players in 2019
Figure 17. Global Top Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapy and Drug Delivery as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Diabetes Therapy and Drug Delivery Revenue in 2019
Figure 19. North America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …- インスリン薬・デリバリー技術の世界市場（～2026年） Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along w…
- ドラッグデリバリーシステム（DDS）の世界市場（～2026年） Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. Market Analysis and Insights: Global Drug Delivery Systems Market The global Drug Delivery Systems market size is projecte…
- 高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…